– ISRAEL, Tel Aviv – Alcobra Ltd. (Nasdaq:ADHD), an emerging pharmaceutical company focused on the development of new medications to help patients with cognitive disorders, including Attention Deficit Hyperactivity Disorder (ADHD) and Fragile X Syndrome, today announced that all proposals were approved at the Company’s annual meeting held today in Tel Aviv, including the election of Dr.…
– UK, Chippenham – Alliance Pharma plc (AIM: APH), the speciality pharmaceutical company, is pleased to announce the appointment of Andrew Franklin as Finance Director.…
– USA, IL – Baxalta Incorporated (NYSE: BXLT), a global biopharmaceutical leader dedicated to delivering transformative therapies to patients with orphan diseases and underserved conditions, announces the appointment of two new board members.…
– USA, IL – Walgreens Boots Alliance, Inc. (Nasdaq: WBA) today announced that its board of directors has named Stefano Pessina as CEO, effective immediately.…
– USA, PA – Onconova Therapeutics, Inc. (NASDAQ:ONTX), a clinical-stage biopharmaceutical company focused on discovering and developing novel products to treat cancer, today announced the appointment of James J.…
